Travere Therapeutics shares owned by Context Capital Management
Quarter-by-quarter ownership of Travere Therapeutics shares owned by Context Capital Management
from 13F filings
Historical chart of Context Capital Management investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Context Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $49M | 57k | 864.00 |
| 2024-06-30 | $40M | 61k | 651.25 |
| 2024-03-31 | $39M | 61k | 639.65 |
| 2023-12-31 | $35B | 53M | 660.00 |
| 2023-09-30 | $27M | 41k | 649.11 |
| 2023-06-30 | $24M | 29k | 804.37 |
| 2023-03-31 | $18M | 18k | 982.99 |
| 2022-12-31 | $21M | 23k | 915.01 |
| 2022-09-30 | $5.1M | 5.0k | 1017.60 |
| 2022-06-30 | $4.1M | 4.1k | 998.05 |
| 2022-03-31 | $6.1M | 5.8k | 1067.48 |
More positions owned by Context Capital Management
View all positions for Context Capital Management